DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.8% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $463.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0001310204-26-000006
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$463.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$154.43
Trade value
$463.29K
% of position
1.8%
2/17/2026
170.78K→167.78K
Total
Net shares
−3K
Net value
-$463.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | S · Sale | −3K | $154.43 | $463.29K | 1.8% | 170.78K | 167.78K |
| Total | −3K | -$463.29K | ||||||
Derivative Transactions0
No derivative transactions reported